A detailed history of O'Shaughnessy Asset Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 11,976 shares of ALKS stock, worth $289,699. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,976
Previous 9,879 21.23%
Holding current value
$289,699
Previous $274,000 18.25%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$26.4 - $32.56 $55,360 - $68,278
2,097 Added 21.23%
11,976 $324,000
Q4 2023

Feb 09, 2024

SELL
$23.37 - $28.68 $51,624 - $63,354
-2,209 Reduced 18.27%
9,879 $274,000
Q3 2023

Nov 13, 2023

BUY
$27.17 - $31.97 $58,469 - $68,799
2,152 Added 21.66%
12,088 $338,000
Q2 2023

Aug 11, 2023

BUY
$28.34 - $33.63 $11,137 - $13,216
393 Added 4.12%
9,936 $310,000
Q1 2023

May 12, 2023

SELL
$25.31 - $29.02 $69,298 - $79,456
-2,738 Reduced 22.29%
9,543 $269,000
Q4 2022

Feb 10, 2023

SELL
$21.94 - $26.24 $24,199 - $28,942
-1,103 Reduced 8.24%
12,281 $320,000
Q3 2022

Nov 14, 2022

SELL
$22.0 - $31.87 $37,774 - $54,720
-1,717 Reduced 11.37%
13,384 $299,000
Q2 2022

Aug 11, 2022

SELL
$26.4 - $30.54 $5,491 - $6,352
-208 Reduced 1.36%
15,101 $450,000
Q1 2022

May 13, 2022

SELL
$23.07 - $27.99 $10,796 - $13,099
-468 Reduced 2.97%
15,309 $403,000
Q4 2021

Feb 11, 2022

BUY
$21.47 - $32.08 $80,448 - $120,203
3,747 Added 31.15%
15,777 $367,000
Q3 2021

Nov 10, 2021

BUY
$23.37 - $32.13 $280,510 - $385,656
12,003 Added 44455.56%
12,030 $372,000
Q2 2021

Aug 09, 2021

BUY
$18.78 - $25.15 $507 - $679
27 New
27 $1,000
Q1 2021

May 14, 2021

SELL
$18.21 - $23.2 $491 - $626
-27 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$13.31 - $19.41 $359 - $524
27 New
27 $1,000
Q1 2020

May 13, 2020

SELL
$13.06 - $21.24 $679 - $1,104
-52 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$17.29 - $21.74 $899 - $1,130
52 New
52 $1,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $3.97B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.